|
Terumo medical received a letter from abbott, abbott per-2024-0167633, in regard to an adverse event.The description states: "the report was concerning the.018" x 300 cm glidewire advantage manufactured by terumo.It was reported that a cardiomems implant procedure was abandoned due to hemoptysis.During a cardiomems implant procedure, the cardiomems delivery catheter was advanced over an 0.018" x 300 cm glidewire advantage.Before the delivery catheter entered the right ventricular outflow tract (rvot), the patient began to cough and was found to have blood in their mouth.The procedure was then abandoned due to hemoptysis.The abbott rep confirmed that no interventions were needed to stop the hemoptysis and fluoroscopy during the procedure was performed to identify potential causes.The physician felt that the cause of the hemoptysis was damage to the distal pulmonary artery caused by the glidewire advantage.The patient was admitted to the intense care unit (icu).After the procedure for monitoring and released on (b)(6) 2024.The procedure performed was cardiomems implant.There was no medical or surgical intervention required.
|
|
A1: patient identifier: requested, not provided.A2: age or date of birth: requested, not provided.A3a: sex: requested, not provided.A3b: gender: n/a.A4: weight: requested, not provided.A5: ethnicity: requested, not provided.A6: race: requested, not provided.D4: lot #: requested, unknown.D4: expiration date: unknown, as the involved product lot # was unknown.D6a: implanted date: device was not implanted.D6b: explanted date: device was not explanted.H4: device manufacture date: unknown, as the involved product lot # was unknown.The actual sample was not returned.Since the lot number was unknown, the manufacturing record and the shipping inspection record could not be investigated.In the past three years, we have not received any similar complaints of the involved products caused by the manufacturing process.Since the lot number was unknown, history investigation could not be performed.In addition, since the actual sample was not returned and investigation of it could not be performed, it was not possible to clarify the cause of occurrence.Ashitaka factory has been making efforts in maintaining the quality of the product by performing following controls.The outer diameter of this product is controlled.In the product assembling process, 100% visual inspection is performed to confirm that there is no anomaly in the appearance.The instructions for use (ifu) of this product includes the following warning: "if any resistance is felt or if the tip's behavior and/or location seems improper, stop manipulating the glidewire advantage and/or the catheter and determine the cause by fluoroscopy.Continuing to manipulate or rotate the glidewire advantage or failure to exercise proper caution may result in bending, kinking, separation of the guide wire's tip, damage to the catheter, or damage to the vessel." terumo medical corporation (tmc) (importer) registration no.(b)(4) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(4).For information regarding the importer report for this event, please refer to section h10.
|